Baxter International Inc. Share Price Berne S.E.
Equities
BAX
US0718131099
Medical Equipment, Supplies & Distribution
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
38.11 CHF | +3.50% | -.--% | -.--% |
Sales 2024 * | 1.51TCr 1.35TCr 1,26200Cr | Sales 2025 * | 1.57TCr 1.4TCr 1,30800Cr | Capitalization | 1.74TCr 1.55TCr 1,45000Cr |
---|---|---|---|---|---|
Net income 2024 * | 70Cr 63Cr 5.87TCr | Net income 2025 * | 95Cr 85Cr 7.93TCr | EV / Sales 2024 * | 1.8 x |
Net Debt 2024 * | 984.69Cr 880.06Cr 82TCr | Net Debt 2025 * | 905.57Cr 809.35Cr 76TCr | EV / Sales 2025 * | 1.69 x |
P/E ratio 2024 * |
18.5
x | P/E ratio 2025 * |
15.2
x | Employees | - |
Yield 2024 * |
3.51% | Yield 2025 * |
3.64% | Free-Float | 74.27% |
Latest transcript on Baxter International Inc.
1 day | +3.50% |
Managers | Title | Age | Since |
---|---|---|---|
Joe Almeida
CEO | Chief Executive Officer | 61 | 01/15/01 |
Joel Grade
DFI | Director of Finance/CFO | 54 | 18/23/18 |
Reaz Rasul
CTO | Chief Tech/Sci/R&D Officer | - | 01/17/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Oesterle
BRD | Director/Board Member | 73 | 06/17/06 |
Peter Wilver
BRD | Director/Board Member | 64 | 10/22/10 |
Director/Board Member | 64 | 18/19/18 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.54% | 18TCr | |
-0.32% | 11TCr | |
-2.05% | 6.9TCr | |
-7.14% | 4.58TCr | |
+12.24% | 4.54TCr | |
+8.60% | 4.32TCr | |
+15.37% | 2.99TCr | |
+13.65% | 2.55TCr | |
-6.64% | 2.39TCr |
- Stock Market
- Equities
- BAX Stock
- BAX Stock